Bayesian Propensity Scores for High-Dimensional Causal Inference: A Comparison of Drug-Eluting to Bare-Metal Coronary Stents

TL;DR

This paper introduces Bayesian propensity score methods tailored for high-dimensional causal inference, demonstrating their effectiveness through simulations and real-world cardiac stent data analysis with numerous confounders.

Contribution

It presents a novel simple estimator for average treatment effects leveraging conjugacy, and evaluates Bayesian methods like horseshoe priors and BART in high-dimensional settings.

Findings

Bayesian methods outperform frequentist approaches in high-dimensional data.

The new estimator effectively captures treatment effect uncertainty.

Including variance from treatment and outcome models improves estimates.

Abstract

High-dimensional data can be useful for causal inference by providing many confounders that may bolster the plausibility of the ignorability assumption. Propensity score methods are powerful tools for causal inference, are popular in health care research, and are particularly useful for high-dimensional data. Recent interest has surrounded a Bayesian formulation of these methods in order to flexibly estimate propensity scores and summarize posterior quantities while incorporating variance from the (potentially high-dimensional) treatment model. We discuss methods for Bayesian propensity score analysis of binary treatments, focusing on modern methods for high-dimensional Bayesian regression and the propagation of uncertainty from the treatment regression. We introduce a novel and simple estimator for the average treatment effect that capitalizes on conjugancy of the beta and binomial distributions. Through simulations, we show the utility of horseshoe priors and Bayesian additive regression trees paired with our new estimator, while demonstrating the importance of including variance from the treatment and outcome models. Cardiac stent data with almost 500 confounders and 9000 patients illustrate approaches and compare among existing frequentist alternatives.